Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q3 2026, worth $7.55M in total; no superinvestor holds it.
Holders of 5% or more of LSTA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lisata Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Branham Justin Earl | 13G | 5.10%462.1K shares | New | Aug 26, 20261 filing | Aug 26, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Lisata Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 26, 20261:02 PM ET | Branham Justin Earl | 13G | 5.10%462.1K shares | New | Aug 21, 2026 | SEC |
| Feb 14, 2022 | CVI Investments, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2022 | MMCAP International Inc. SPC | 13G/AOld format | – | – | – | SEC |
| Jan 19, 2022 | Empery Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 24, 2021 | CVI Investments, Inc. | 13GOld format | – | New | – | SEC |
| Feb 22, 2021 | MMCAP International Inc. SPC | 13GOld format | – | New | – | SEC |
| Feb 22, 2021 | Intracoastal Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 18, 2021 | Empery Asset Management, LP | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Renaissance Technologies LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Lisata Therapeutics, Inc. shares.
No Form 144 notices for Lisata Therapeutics, Inc. are on file.